Abiomed

Abiomed Inc.
Industry Medical Devices
Founded 1981
Headquarters Danvers, MA United States and Aachen, Germany
Key people
 Michael R. Minogue, CEO, President & Chairman of the board
Mr. Robert L. Bowen, CFO
Dr. David Weber, COO
Products AbioCor
Impella
iPulse
IAB
AB5000
BVS 5000
Revenue Increase US$73.2 Million (FY 2009)[1]
Decrease US$-29.5 Million (FY 2009)[1]
Decrease US$-31.6 Million (FY 2009)[1]
Total assets Increase US$136 Million (FY 2009)[2]
Total equity Increase US$116 Million (FY 2009)[2]
Number of employees
 500 (2013)
Slogan Recovering hearts. Saving lives.
Website www.abiomed.com

Abiomed (NASDAQ: ABMD) is a manufacturer of medical implant devices, including the AbioCor artificial heart and Impella. It is headquartered in Danvers, Massachusetts and has an additional office in Aachen, Germany. It has 500 employees. Michael R. Minogue joined Abiomed in 2004, and as CEO, Chairman and President. Minogue is a military veteran who served for four years on active duty in the U.S. Army and for eight years in the Army’s Individual Ready Reserve. Minogue served in Operation Desert Storm and earned multiple distinctions, including the Bronze Star. He is a 1989 graduate of the United States Military Academy at West Point. Minogue helped found the Medical Technology Veterans Program (MVP), a yearlong career training and mentorship initiative designed to help veterans entering the civilian workforce transition into jobs in the medical device and diagnostic industries.(*) He currently serves as chairman of the program.

Board of Directors

Abiomed Board of Directors include Michael R. Minogue, CEO, W. Gerald Austen, Harvard Medical School and the Massachusetts General Hospital, Louis E. Lataif, Boston University School of Management, Dorothy E. Puhy, Dana Farber Cancer Institute, Martin P. Sutter, Essex Woodlands Health Ventures, Henri A. Termeer, former-CEO Genzyme, Paul G. Thomas, CEO Roka Bioscience.[3]

References

  1. 1 2 3 ABIOMED (ABMD) annual SEC income statement filing via Wikinvest
  2. 1 2 ABIOMED (ABMD) annual SEC balance sheet filing via Wikinvest
  3. ↑ "BOD". Abiomed. nd. Retrieved 27 September 2015.

External links

This article is issued from Wikipedia - version of the Wednesday, October 28, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.